Standigm Inc., founded by researchers from Samsung Advanced Institute of Technology, specializes in AI-driven drug discovery by generating and optimizing therapeutic compounds. The company emphasizes its innovative platforms for novel target identification and chemical space exploration, while leveraging advanced machine learning techniques and patent strategies. Key resources and technologies discussed include proprietary AI models, chemical databases, and OCR enhancements for patent analysis.